US20220225997A1

US20220225997A1 - Aneurysm treatment device

Info

Publication number: US20220225997A1
Application number: US17/658,263
Authority: US
Inventors: Ariel SOTO DEL VALLE; Lacey GOROCHOW; Juan Lorenzo
Original assignee: DePuy Synthes Products Inc
Current assignee: DePuy Synthes Products Inc
Priority date: 2019-03-27
Filing date: 2022-04-07
Publication date: 2022-07-21
Also published as: US20200305886A1; EP3714812A1; KR20200115320A; JP2020157065A; US11337706B2; CN111743592A

Abstract

An implant having an elongated portion and an expandable braided sack portion can be delivered through a catheter and implanted in an aneurysm such that elongated portion loops within the braided sack, the braided sack contacts a majority or all of the aneurysm wall, and the braided sack at least partially occludes the aneurysm neck.

Description

CROSS REFERENCE TO RELATED APPLICATION

The present application is a continuation application of U.S. patent application Ser. No. 16/366,235 filed Mar. 27, 2019, the entire contents of which are hereby incorporated by reference.

FIELD OF INVENTION

The present invention generally relates to medical instruments, and more particularly, to embolic implants for aneurysm therapy.

BACKGROUND

Cranial aneurysms can be complicated and difficult to treat due to their proximity to critical brain tissues. Prior solutions have included endovascular treatment whereby an internal volume of the aneurysm sac is removed or excluded from arterial blood pressure and flow. Current alternatives to endovascular or other surgical approaches can include intravascularly delivered treatment devices that either fill the sac of the aneurysm with embolic material or block the entrance or neck of the aneurysm. Both approaches attempt to prevent blood flow into the aneurysm. When filling an aneurysm sac, the embolic material clots the blood, creating a thrombotic mass within the aneurysm. When treating the aneurysm neck, blood flow into the entrance of the aneurysm is inhibited, inducing venous stasis in the aneurysm and facilitating a natural formation of a thrombotic mass within the aneurysm.
Current intravascularly delivered devices typically utilize multiple embolic coils to either fill the sac or treat the entrance. Naturally formed thrombotic masses formed by treating the entrance of the aneurysm with embolic coils can improve healing compared to aneurysm masses packed with embolic coils by reducing possible distention from arterial walls and permitting reintegration into the original parent vessel shape along the neck plane. However, embolic coils delivered to the neck of the aneurysm can potentially have the adverse effect of impeding the flow of blood in the adjoining blood vessel; at the same time, if the entrance is insufficiently packed, blood flow can persist into the aneurysm. Treating certain aneurysm morphology (e.g. wide neck, bifurcation, etc.) can required ancillary devices such a stents or balloons to support the coil mass and obtain the desired packing density. Once implanted, the coils cannot easily be retracted or repositioned. Furthermore, embolic coils do not always effectively treat aneurysms as aneurysms treated with multiple coils often recanalize or compact because of poor coiling, lack of coverage across the aneurysm neck, because of flow, or large aneurysm size.
Alternatives to embolic coils are being explored, for example a tubular braided implant is disclosed in US Patent Publication Number 20180242979, incorporated herein by reference. Tubular braided implants have the potential to easily, accurately, and safely treat an aneurysm or other arterio-venous malformation in a parent vessel without blocking flow into perforator vessels communicating with the parent vessel. Compared to embolic coils, however, tubular braided implants are a newer technology, and there is therefore capacity for improved geometries, configurations, delivery systems, etc. for the tubular braided implants.
There is therefore a need for improved methods, devices, and systems for implants for aneurysm treatment.

SUMMARY

It is an object of the present invention to provide systems, devices, and methods to meet the above-stated needs. Generally, in examples herein, an implant having an elongated portion and an expandable braided sack portion can be delivered through a catheter and implanted in an aneurysm such that elongated portion loops within the braided sack and the braided sack at least partially occludes the aneurysm neck.
An example implant can include an expandable braided sack portion, an elongated looping portion joined to the braided sack portion, and a detachment feature joined to the elongated looping portion. The implant can move from a delivery configuration to an implanted configuration. In the delivery configuration, the implant can be sized to be delivered through a lumen of a catheter to a treatment site, and in the implanted configuration, the implant can be sized to secure within an aneurysm. In the delivery configuration, the expandable braided sack portion can extend from a distal end of the implant, the elongated looping portion can extend proximally from the expandable braided sack portion, the detachment feature can be positioned near a proximal end of the implant, and the detachment feature can be detachably attached to a delivery system.
The expandable braided sack portion can be unattached to the delivery system when the implant is in the delivery configuration, in the implanted configuration, and throughout the transition from the delivery configuration to the implanted configuration during treatment of an aneurysm. In the implanted configuration, the expandable braided sack portion can be sized to contact a majority of an interior wall of the aneurysm, can contain the elongated looping portion, and can occlude some or all of the opening of the neck of the aneurysm. The expandable braided sack portion can have a free end, and in the implanted configuration, the free open end can be positioned at the aneurysm neck. In the implanted configuration the elongated looping portion can wind within the expandable braided sack portion.
In the delivery configuration the implant can have a fold at its' distal end, the expandable braided sack portion can encompass some of the elongated looping portion, and the free open end of the expandable braided sack portion can encircle the elongated looping portion. In the implanted configuration, a fold can define a boundary between the elongated looping portion and the expandable braided sack portion, and the fold can be positioned along a distal surface of the interior aneurysm wall. the fold at the distal end of the implant in the delivery configuration can be the same fold positioned along the distal surface of the aneurysm wall in the implanted configuration.
Alternatively, in the delivery configuration, the free open end can be positioned at the distal end of the implant and the implant can extend from the free open end at the distal end of the implant to the detachment feature at the proximal end of the implant. When the implant configured thusly, exits a catheter and the braided sack portion enters the aneurysm, a fold can form, and the fold can be positioned along a distal surface of the interior aneurysm wall.
The elongated looping portion and the expandable braided sack portion can be portions of a contiguous tubular braid. A fold can define a boundary between the elongated looping portion and the expandable braided sack portion, and the elongated looping portion can have a length measurable from the fold to the detachment feature. The elongated looping portion of the contiguous tubular braid can have a substantially uniform circumference along most of its length
Alternatively, the elongated looping portion can have an embolic coil and the expandable braided sack portion can be a tubular braid.
When the implant is implanted and left in an aneurysm at the completion of an aneurysm treatment, the implant can include only the sack portion, the elongated looping portion, and the detachment feature. The implant need not have any other features such as additional detachment features or anchoring elements.
An example method of treating an aneurysm can include one or more of the following steps presented in no particular order, and the method can include additional steps not included here. An implant having an expandable portion and an embolic coiling portion can be provided. The embolic coiling portion can be detachably attached to a delivery system. The implant can be positioned within a microcatheter such that the embolic coiling portion extends distally from a proximal end of the implant, the expandable portion extends proximally from the distal end of the implant, and the expandable portion is unattached to the delivery system. The distal end of the microcatheter can be positioned near the aneurysm neck. The implant can be delivered through the microcatheter to the distal end of the microcatheter. The expandable portion can be expelled from the distal end of the microcatheter. The expandable portion can be expanded to contact a majority of the interior wall of the aneurysm. The embolic coiling portion can be expelled from the distal end of the microcatheter. The embolic coiling portion can be placed to wind within the expanded expandable portion. The embolic coiling portion can be detached from the delivery system.
When the implant is positioned in a microcatheter, a fold can be positioned at the distal end of the implant and the expandable portion can be positioned to encompass at least a portion of the embolic coiling portion. Alternatively, when the implant is positioned in a microcatheter, a free open end of the implant can be positioned at the distal end of the implant.
The expandable portion can be anchored to the interior wall of the aneurysm, and the expandable portion can be placed to inhibit the embolic coiling portion from exiting a sac of the aneurysm. The expandable portion can have a free open end, and the free open end can be positioned at the aneurysm neck. The implant can be folded to create a fold that defines a boundary between the expandable portion and the embolic coiling portion. The fold can be positioned near a distal surface of the interior aneurysm wall.
When the implant having the expandable portion and the embolic portion is provided, a contiguous tubular braid can be provided, and the expandable portion and the embolic portion can be portions of the contiguous tubular braid. When the embolic coiling portion of the contiguous braid is placed to wind within the expanded expandable portion, a substantially uniform circumference can be maintained along most of the length of the embolic coiling portion. Alternatively, when the implant having the expandable portion and the embolic portion is provided, a tubular braid joined an embolic coil can be provided such that the tubular braid includes the expandable portion and the embolic coil includes the embolic portion.
A detachment feature can be provided and affixed to the embolic coiling portion. The detachment feature can be detachably attached to the delivery system. To implant the expandable portion, embolic coiling portion, and the detachment feature in the aneurysm, the detachment feature can be detached from the delivery system. When the detachment feature is detached, only the expandable portion, embolic coiling portion, and the detachment feature can remain implanted in the implant.
Another example method for treating an aneurysm can include one or more of the following steps presented in no particular order, and the method can include additional steps not included here. An implant can be provided having a braided portion and an embolic portion. The braided portion can include a memory shape material and can have a spherical or globular predetermined shape. The embolic portion can be detachably attached to an implant delivery system. The implant and the delivery system can be positioned within a lumen of a microcatheter. When the implant and the delivery system is positioned in the microcatheter, the braided portion can be collapsed to fit in the lumen and positioned in the lumen to extend proximally from the distal end of the implant, the embolic portion can be positioned to extend distally from the proximal end of the implant, and the delivery system can be positioned to extend proximally from the embolic portion. The implant and the delivery system can traverse through the lumen of the microcatheter while the braided portion is unattached to the delivery system. The implant can be expelled from the microcatheter. When the implant is expelled, the braided portion can be expelled from the microcatheter and expanded to form a sack shape based on the spherical predetermined shape, the embolic portion can be expelled from the microcatheter and coiled within the sack shape of the braided portion. When the implant is expelled, an opening can be positioned in the sack shape of the braided portion can be positioned near the aneurysm neck, a fold can be positioned to define a boundary between the braided portion and the embolic portion near a distal surface of the aneurysm wall, and the embolic portion can traverse through the opening in the sack shape.

BRIEF DESCRIPTION OF THE DRAWINGS

The above and further aspects of this invention are further discussed with reference to the following description in conjunction with the accompanying drawings, in which like numerals indicate like structural elements and features in various figures. The drawings are not necessarily to scale, emphasis instead being placed upon illustrating principles of the invention. The figures depict one or more implementations of the inventive devices, by way of example only, not by way of limitation.

FIGS. 1A through 1C are illustrations of an example implant in a collapsed or delivery configuration (FIG. 1A), a cross section of the collapsed implant of FIG. 1A (FIG. 1C), and the example implant in an implanted or expanded configuration (FIG. 1B) according to aspects of the present invention;

FIGS. 2A through 2E are illustrations of an example implant during implantation steps according to aspects of the present invention;

FIGS. 3A and 3B are illustrations of an example implant in a collapsed or delivery configuration (FIG. 3A) and in an implanted or expanded configuration (FIG. 3B) according to aspects of the present invention;

FIGS. 4A and 4B are illustrations of an example implant in a collapsed or delivery configuration (FIG. 4A) and in an implanted or expanded configuration (FIG. 4B) according to aspects of the present invention;

FIGS. 5A through 5E are illustrations of an example implant during implantation steps according to aspects of the present invention;

FIGS. 6A and 6B are illustrations of an example implant in a collapsed or delivery configuration (FIG. 6A) and in an implanted or expanded configuration (FIG. 6B) according to aspects of the present invention; and

FIGS. 7 through 10 are flow diagrams outlining example method steps for treating an aneurysm according to aspects of the present invention.

DETAILED DESCRIPTION

As object of the present invention is to provide an embolic implant suitable for endovascular treatment of an aneurysm in a patient. The implant can have two parts that can reshape upon delivery to a treatment site.
FIG. 1A illustrates an example implant 200 in a collapsed or delivery configuration. In the delivery configuration, the implant 200 can be sized to be delivered to a treatment site through a catheter inserted in vasculature of a patient. FIG. 1C illustrates a cross sectional view of the collapsed implant 200 as indicated in FIG. 1A. FIG. 1B illustrates the example implant 200 illustrated in FIG. 1A in an expanded or implanted configuration. In the implanted configuration, the implant 200 can be positioned in a sac 12 of an aneurysm 10 to divert blood flow from a neck 16 of the aneurysm 10 and fill the sac 12 with embolic material. The embolic material in the aneurysm sac 12 can promote the formation of a thrombotic mass in the aneurysm 10, and the diversion of blood flow from the aneurysm neck 16 can induce venous stasis in the aneurysm and reduce the likelihood that the aneurysm recanalizes after an aneurysm treatment procedure.
Referring collectively to FIGS. 1A through 1C, the implant 100 can include an elongated portion 204, an expandable sack portion 202, and a detachment feature 230. The elongated portion 204 and the expandable sack portion 202 can each be braided. The expandable sack portion 202 and elongated portion 204 can be manufactured as two separate structures or as a contiguous braided structure. Braided portions can be made from braided Nitinol, cobalt, chromium, plastic, or other suitable material. Portions of the implant 200 can be made from a memory shape material having a predetermined shape and a deformed shape. The memory shape material can be in the deformed shape when the implant 200 is in the delivery configuration and can move toward the predetermined shape when the implant 200 is in the expanded or implanted configuration. When implanted, the memory shape material can be restricted by anatomical geometries and the memory shape material can take a shape that approaches the predetermined shape but does not match the predetermined shape due to the anatomical restrictions.
The detachment feature 230 can be joined to the elongated portion 204, and the detachment feature 230 can be detachably attached to a delivery system when the implant 200 is delivered through a catheter to a treatment site.
Referring to FIG. 1A, in the delivery configuration, the detachment feature 230 can be positioned at the proximal end 212 of the implant 200, the elongated portion 204 can extend distally from the detachment feature 230 to a fold 203 positioned at a distal end 214 of the implant 200, and the expandable braided sack portion 202 can extend proximally from the fold 203. In the delivery configuration, the expandable braided sack portion 202 can extend distally from the fold 203 to wrap around a part of the length L of the elongated portion 204, and the expandable braided sack portion 202 can have an open end 226 that circles the elongated portion 204. The open end 226 is preferably simply the open end of a braid without any ancillary attachments. The open end 226 need not be attached to a delivery system as the implant 200 is delivered through a catheter to the treatment site or as the implant 200 is deployed within the aneurysm. Strands of the braid 210 at the open end 226 can be free, cut ends; or, alternatively, the strands at the open end 226 be closed, meaning strands within the braid at the open end are attached to each other by glue, weld, etc. or the strands bend back at the open end. Free cut ends can have an advantage of being easier to manufacture while the closed ends can have an advantage of being more atraumatic compared to the cut ends.
Referring to FIGS. 1A and 1B, the implant 200 can include memory shape material and can be pre-shaped such that the expandable braided sack portion 202 forms a globular or spherical shape and a fold 203 separates the elongated looping portion 204 from the expandable braided sack portion 202. The memory shape material can be heat set into the predetermined shape. The spherical shape, fold 203, and the loops of the elongated portion can be shaped by heat setting. The implanted shape illustrated in FIG. 1B can be based on the predetermined shape and the shape of the interior wall 14 of the aneurysm 10. To collapse the implant from the predetermined shape so that it can be delivered through a catheter, the elongated looping portion 204 can be extended and straightened and the sack portion 202 can be compressed around the elongated looping portion 204. The fold created when the implant was pre-shaped can be further folded to define a boundary between the sack portion 202 and the elongated looping portion 204 when the implant 200 is in the delivery configuration.
Referring to FIG. 1B, in the implanted configuration, the expandable braided sack portion 202 can expand to contact a majority of the interior wall 14 of the aneurysm 10. The fold 203 can be positioned near a distal surface 15 of the aneurysm wall 14. The elongated portion 204 can wind within the aneurysm sac 12 and within the braided sack portion 202. By anchoring within the sac 12, the expandable braided sack portion 202 can maintain proper positioning of the implant 200 in the aneurysm 10 and prevent portions of the implant 200, such as the elongated portion 204, from extending into a blood vessel 20 a, 20 b, 21 or exiting the aneurysm sac 12.
The free open end 226 of the expandable braided sack portion 202 can define an opening in the sack when the implant is in the implanted or pre-shaped configuration, and when implanted, the opening can be positioned near the aneurysm neck 16. The opening can be sized such that a portion of the expandable braided sack portion 202 extends across the aneurysm neck 16 to occlude the neck. The elongated portion 204 can enter the aneurysm sac 12 and the sack of the expandable braided sack portion 202 through the opening. The elongated portion 204 can wind or loop around in a complex coiled shape within the expandable braided sack portion 202 and within the aneurysm sac 12. The looped elongated portion 204 can press against the braided sack 202 and provide a force against an interior surface of the braided sack 202 to press an exterior surface of the braided sack 202 to the aneurysm wall 14 to further secure the anchoring of the braided sack 202 within the aneurysm sac 12.
The looped elongated portion 204 can fill a majority of the aneurysm sac 12. The implanted braided sack 202 can be a braided mesh with a porosity sized to inhibit blood flow into the aneurysm 10. The elongated portion can have a substantially uniform circumference 206 along much or all of its length L, and it can maintain the substantially uniform circumference 206 as it moves from the delivery configuration to the implanted configuration.
FIGS. 2A through 2E are illustrations of an example implant during implantation steps. FIG. 2A illustrates an implant 200 positioned within a catheter 600 near an aneurysm 10. The aneurysm 10 is illustrated positioned at a bifurcated blood vessel having a stem vessel 21, a first side branch vessel 20 a, and a second side blood vessel 20 b. The catheter 600 can approach the aneurysm 10 from the stem vessel 21. It is contemplated that example implants 200 disclosed herein can be used for treating sidewall vessels according to methods described herein and as would be understood by a person of ordinary skill in the art. At the instant illustrated in FIG. 2A, the implant 200 is collapsed in the catheter 600. The implant 200 can include memory shape material that is in a deformed shape while it is collapsed in the catheter 600.
FIG. 2B illustrates the implant 200 during implantation. The implant 200 can include an expandable braided sack portion 202 and an elongated embolic portion 204. As the implant 200 is translated distally through the catheter 600, a fold 203 can be positioned at a distal end 214 of the implant 200, and the expandable braided sack portion 202 and the elongated looping portion 204 can extend proximally from the fold 203. Configured thusly, the braided sack portion 202 can be oriented in the catheter 600 so that when the implant 200 is pushed distally out of the catheter 600, the braided sack portion 202 is pushed out of the catheter 600 and into the sac 12 before a majority of the elongated looping portion 204 is begins to exit the catheter 600.
FIG. 2C illustrates the implant 200 after the braided sack portion 202 has exited the catheter 600 and expanded within the aneurysm 12. The braided sack portion 202 can expand to contact all or a majority of the interior wall 14 of the aneurysm 10. The braided sack 202 can expand toward the predetermined shape upon exiting the catheter 600. Contact with warm bodily fluid can cause the memory shape material in the braided sack 202 to move to the predetermined shape. The free open end 226 can define an opening in the braided sack 202, and the opening can be positioned at the aneurysm neck 16.
A fold 203 defining a boundary between the expanded braided sack 202 and the elongated portion 204 can be positioned near a distal surface 15 of the aneurysm wall 14. At the stage of implantation illustrated in FIG. 2C, the elongated portion 204 can extend from the fold 203, through the opening in the braided sack 202, and into the catheter 600.
FIG. 2D illustrates the elongated portion 204 exiting the catheter 600, entering the braided sack portion 202 through the free open end 226, and winding within the sack 202. As the elongated portion 204 exits the catheter 600, the elongated portion 204 can maintain its circumference 206 as it exits the catheter 600. The elongated portion 204 can wind or loop within the aneurysm sac 12 in response to contacting an interior surface of the expanded braided sack 202. Additionally, or alternatively, the elongated portion 204 can include memory shape material having a predetermined shape and a deformed shape. The predetermined shape can be a complex looped shape, and the deformed shape can be substantially straight. The elongated portion 204 can wind or loop within the aneurysm sac 12 in response to the memory shape material moving from the deformed shape toward the predetermined shape as the elongated portion 204 contacts blood as it exits the catheter 600. Additionally, or alternatively, the elongated portion 204 can include a flexible elastically deformable material having a relaxed shape that is a looped shape. The flexible elastically deformable material can be uncoiled to a substantially straight strand during delivery through a catheter and can collapse into the looped shape upon exiting the catheter 12.
At the instant illustrated in FIG. 2D the detachment feature 230 can remain attached to a delivery system. While the implant 200 is attached to the delivery system, the delivery system can be pulled proximally to withdraw all or portions of the implant 200. The delivery system can subsequently be pushed distally to reposition the implant 200.
FIG. 2E illustrates the implant 200 in a final implanted configuration such as described in relation to FIG. 1B. The detachment feature 230 can be moved distally by the delivery system past the plane of the aneurysm 16, through the open end 226 of the expanded sack portion 202, and into the aneurysm sac 12 prior to detachment from the delivery system. The elongated portion 204 can have a predetermined shape configured to facilitate the movement of the detachment feature 230 past the plane of the aneurysm neck 16 once the implant 200 is implanted. Additionally, or alternatively, the delivery system can be manipulated to place the detachment feature 230 within the sack portion 202. Once the implant 200 is implanted as illustrated in FIG. 2E, the delivery system can be detached and withdrawn, and the microcatheter 600 can be moved or extracted from the patient.
The open end 226 can remain open at the completion of the implantation, and the elongated portion 204, once secured within the sack 202, can be coiled near the opening defined by the open end 226 in such a way that blood flow is obstructed from entering the opening. In other words, sack 202 can occlude a portion of the neck 16 around the perimeter of the neck, and the elongated portion 204 can occlude the neck 16 at the opening in the sack 202 defined by the open end 226.
FIG. 3A illustrates an example implant 200 a in a collapsed or delivery configuration. In the delivery configuration, the implant 200 a can be collapsed to a size that can be delivered to a treatment site through a catheter inserted in vasculature of a patient. FIG. 3B illustrates the example implant 200 a illustrated in FIG. 3A in an expanded or implanted configuration. In the implanted configuration, the implant 200 a can be positioned in a sac 12 of an aneurysm 10 to divert blood flow from a neck 16 of the aneurysm 10 and fill the sac 12 with embolic material. The embolic material in the aneurysm sac 12 can promote the formation of a thrombotic mass in the aneurysm 10, and the diversion of blood flow from the aneurysm neck 16 can induce venous stasis in the aneurysm and reduce the likelihood that the aneurysm recanalizes after an aneurysm treatment procedure.
Comparing the example implant 200 a illustrated in FIGS. 3A and 3B to the implant 200 illustrated in FIGS. 1A through 2E, the elongated portion 204 a of the implant 200 a in FIGS. 3A and 3B can be an embolic coil 204 a rather than a braid 204 as illustrated in FIGS. 1A through 2E. The implant 200 a illustrated in FIGS. 3A and 3B can be implanted following a procedure like that illustrated in FIGS. 2A through 2E.
Referring collectively to FIGS. 3A and 3B, the implant 200 a can include the embolic coil 204 a, an expandable braided sack portion 202 a, a detachment feature 230 a, and a connecting band 222 joining the embolic coil 204 a to the expandable braid 202 a. The connecting band 222 can include radiopaque material to facilitate visibility of the implant 200 a under X-ray. The expandable braided sack portion 202 a can be braided. Portions of the implant 200 a, including the embolic coil 204 a, can be made from a memory shape material having a predetermined shape and a deformed shape. The memory shape material can be in the deformed shape when the implant 200 a is in the delivery configuration and can move toward the predetermined shape when the implant 200 a is in the expanded or implanted configuration. When expanded or implanted, the memory shape material can be restricted by anatomical geometries and the memory shape material can take a shape that approaches the predetermined shape but does not match the predetermined shape due to the anatomical restrictions.
The detachment feature 230 a can be joined to the elongated portion 204 a, and the detachment feature 230 a can be detachably attached to a delivery system when the implant 200 a is delivered through a catheter to a treatment site.
Referring to FIG. 3A, in the delivery configuration, the detachment feature 230 a can be positioned at the proximal end 212 a of the implant 200 a, the elongated portion 204 can extend distally from the detachment feature 230 a to the connecting band 222, the braided portion 202 a can have a fold 203 a positioned at a distal end 214 a of the implant 200 a, and the expandable braided sack portion 202 a can extend proximally from the fold 203 a. In the delivery configuration, the expandable braided sack portion 202 a can extend distally from the fold 203 a to wrap around a part of the length L′ of the embolic coil 204 a, and the expandable braided sack portion 202 a can have a free open end 226 a that circles the embolic coil 204 a. Strands of the braided portion 202 a at the open end 226 a can be free, cut ends; or, alternatively, the strands at the open end 226 a be closed, meaning strands within the braid at the free open end 226 a are attached to each other by glue, weld, etc. or the strands bend back at the open end 226 a. Free cut ends can have an advantage of being easier to manufacture while the closed strand ends can have an advantage of being more atraumatic compared to the cut ends.
Referring to FIGS. 3A and 3B, the implant 200 a can include memory shape material and can be pre-shaped such that the expandable braided sack portion 202 a forms a globular or spherical shape and the braid can have a fold 203 a near the connecting band 222. The memory shape material can be heat set into the predetermined shape. The implanted shape illustrated in FIG. 3B can be based on the predetermined shape and the shape of the interior wall 14 of the aneurysm 10. To collapse the implant from the predetermined shape so that it can be delivered through a catheter, the embolic coil 204 a can be extended and straightened and the sack portion 202 a can be compressed around the elongated looping portion 204 a. The fold created when the implant was pre-shaped can be further folded and positioned at the distal end 214 a of the implant 200 a when the implant 200 a is in the delivery configuration.
Referring to FIG. 3B, in the implanted configuration, the expandable braided sack portion 202 a can expand to contact a majority of the interior wall 14 of the aneurysm 10. The fold 203 a can be positioned near a distal surface 15 of the aneurysm wall 14. The embolic coil 204 a can wind within the aneurysm sac 12 and within the braided sack portion 202 a. By anchoring within the sac 12, the expandable braided sack portion 202 a can maintain proper positioning of the implant 200 a in the aneurysm 10 and prevent portions of the implant 200 a, such as the embolic coil 204 a, from extending into a blood vessel 20 a, 20 b, 21 or exiting the aneurysm sac 12.
The free end 226 a of the expandable braided sack portion 202 a can define an opening in the sack when the implant 200 a is in the implanted or pre-shaped configuration, and when implanted, the opening can be positioned near the aneurysm neck 16. The opening can be sized such that a portion of the expandable braided sack portion 202 a extends across the aneurysm neck 16 to occlude the neck. The embolic coil 204 a can enter the aneurysm sac 12 and the sack of the expandable braided sack portion 202 a through the opening. The elongated portion 204 a can wind or loop around in a complex coiled shape within the expandable braided sack portion 202 a and within the aneurysm sac 12. The looped elongated portion 204 a can press against the braided sack 202 a and provide a force against an interior surface of the braided sack 202 a to press an exterior surface of the braided sack 202 a to the aneurysm wall 14 to further secure the anchoring of the braided sack 202 a within the aneurysm sac 12.
The looped embolic coil 204 a can fill a majority of the aneurysm sac 12. The implanted braided sack 202 a can be a braided mesh with a porosity sized to inhibit blood flow into the aneurysm 10.
As an alternative to shaping the implant in the delivery configuration such that the expandable braided sack portion 202, 202 a envelopes the elongated portion 204, 204 a as illustrated in FIGS. 1A and 3A, the implant can be elongated in the delivery configuration as illustrated in FIGS. 4A and 6A. The implant 200 illustrated in FIGS. 1A and 1B can have an essentially identical predetermined shape and/or implanted configuration compared to the implant 300 illustrated in FIGS. 4A and 4B. Likewise, the implant 200 a illustrated in FIGS. 3A and 3B can have an essentially identical predetermined shape and/or implanted configuration compared to the implant 300 a illustrated in FIGS. 6A and 6B.
Comparing FIGS. 1B and 4B, once implanted, the implants 200, 300 formed of a contiguous tubular braid 210, 310 can be indistinguishable. Likewise, comparing FIGS. 3B and 6B, once implanted, the implants 200 a, 300 a formed of a braided portion 202 a, 302 a and an embolic coil 204 a, 304 a can be indistinguishable. Significant difference between the implants 200, 200 a illustrated in FIGS. 1A through 3B and the implants 300, 300 a illustrated in FIGS. 4A through 6B include presence of the fold 203, 203 a or lack thereof in each respective deformed shape, position of the free open end 226, 226 a, 314, 314 a during delivery, and process of expanding the expandable braided portion 202, 202 a, 302, 302 a within the aneurysm 10 during treatment.
Referring to FIGS. 4A and 4B, an implant 300 can include a contiguous tubular braid 310 and a detachment feature 330. As illustrated in FIG. 4A, in the delivery configuration, the detachment feature 330 can be positioned at the proximal end 312 of the implant 300, the elongated portion 304 can extend distally from the detachment feature 330, the expandable braided sack portion 302 can extend distally from the elongated portion 304, and the expandable braided sack portion 302 can have a free open end positioned at the distal end 314 of the implant 300. In the delivery configuration, the implant 300 need not have any discernable boundary to indicate which portion of the tubular braid 310 is the elongated looping portion 304 and which portion is the expandable sack portion 302. Strands at the open end 314 can be free, cut ends; or, alternatively, the strands at the open end 314 be closed, meaning strands within the braid at the free open end 314 are attached to each other by glue, weld, etc. or the strands bend back at the open end 314. Free cut ends can have an advantage of being easier to manufacture while the closed strand ends can have an advantage of being more atraumatic compared to the cut ends.
The implant 300 can include memory shape material and can be pre-shaped such that the expandable braided sack portion 302 forms a globular or spherical shape and a fold 303 separates the elongated looping portion 304 from the expandable braided sack portion 302. The memory shape material can be heat set into the predetermined shape. The implanted shape illustrated in FIG. 4B can be based on the predetermined shape and the shape of the interior wall 14 of the aneurysm 10. To collapse the implant 300 from the predetermined shape (similar to the implanted configuration illustrated in FIG. 4B) to the deformed shape (such as illustrated in FIG. 4A) so that it can be delivered through a catheter, the elongated looping portion 304 can be extended and straightened, the sack portion 302 can be inverted and stretch, and the fold 303 can be opened and flattened.
Referring to FIG. 4B, in the implanted configuration, the expandable braided sack portion 302 can expand to contact a majority of the interior wall 14 of the aneurysm 10. The fold 303 can be positioned near a distal surface 15 of the aneurysm wall 14. The elongated portion 304 can wind within the aneurysm sac 12 and within the braided sack portion 302. By anchoring within the sac 12, the expandable braided sack portion 302 can maintain proper positioning of the implant 300 in the aneurysm 10 and prevent portions of the implant 300, such as the elongated portion 304, from extending into a blood vessel 20 a, 20 b, 21 or exiting the aneurysm sac 12.
The free end 314 of the expandable braided sack portion 302 can define an opening in the sack when the implant is in the implanted or pre-shaped configuration, and when implanted, the opening can be positioned near the aneurysm neck 16. The opening can be sized such that a portion of the expandable braided sack portion 302 extends across the aneurysm neck 16 to occlude the neck. The elongated portion 304 can enter the aneurysm sac 12 and the sack of the expandable braided sack portion 302 through the opening. The elongated portion 304 can wind or loop around in a complex coiled shape within the expandable braided sack portion 302 and within the aneurysm sac 12. The looped elongated portion 304 can press against the braided sack 302 and provide a force against an interior surface of the braided sack 302 to press an exterior surface of the braided sack 302 to the aneurysm wall 14 to further secure the anchoring of the braided sack 302 within the aneurysm sac 12.
The looped elongated portion 304 can fill a majority of the aneurysm sac 12. The implanted braided sack 302 can be a braided mesh with a porosity sized to inhibit blood flow into the aneurysm 10. The elongated portion can have a substantially uniform circumference 306 along much or all of its length, and it can maintain the substantially uniform circumference 306 as it moves from the delivery configuration to the implanted configuration.
FIGS. 5A through 5E are illustrations of an example implant 300 during implantation steps. FIG. 5A illustrates an implant 300 positioned within a catheter 600 near an aneurysm 10. The aneurysm 10 is illustrated positioned at a bifurcated blood vessel having a stem vessel 21, a first side branch vessel 20 a, and a second side blood vessel 20 b. The catheter 600 can approach the aneurysm 10 from the stem vessel 21. It is contemplated that example implants 300 disclosed herein can be used for treating sidewall vessels according to methods described herein and as would be understood by a person of ordinary skill in the art. At the instant illustrated in FIG. 5A, the implant 300 is collapsed in the catheter 600. The implant 300 can include memory shape material that is in a deformed shape while it is collapsed in the catheter 600.
FIG. 5B illustrates the implant 300 during implantation. The implant 300 can include an expandable braided sack portion 302 and an elongated embolic portion 304. As the implant 300 is translated distally through the catheter 600, the free open end 314 of the expandable braided sack portion 302 can be positioned at a distal end 314 of the implant 300, the expandable portion 302 can extend proximally from its free open end 314, and the elongated embolic or looping portion 304 can extend proximally from the expandable portion 302. Configured thusly, the expandable portion 302 can be completely expelled from the catheter 600 before the elongated portion 304 begins to exit the catheter 600.
As illustrated in FIG. 5B, the expandable braided sack portion 302 can begin to invert after exiting the catheter 600. The free open end 314 can encircle the braid 310, and portions of the braid 310 can be translated through the opening of the free open end 314. The free end 314 of the implant 300 need not be attached to a delivery system for the braided sack portion 302 to invert. The inversion can be a result of the braided sack portion 302 moving toward its predetermined shape.
FIG. 5C illustrates the implant 300 after the braided sack portion 302 has exited the catheter 600 and expanded within the aneurysm 12. The braided sack portion 302 can expand to contact all or a majority of the interior wall 14 of the aneurysm 10. The braided sack 302 can expand toward the predetermined shape upon exiting the catheter 600. Contact with warm bodily fluid can cause the memory shape material in the braided sack 302 to move to the predetermined shape. The free open end 314 can define an opening in the braided sack 302, and the opening can be positioned at the aneurysm neck 16.
A fold 303 defining a boundary between the expanded braided sack 302 and the elongated portion 304 when in the implant 300 is in the implanted configuration can be positioned near a distal surface 15 of the aneurysm wall 14. At the stage of implantation illustrated in FIG. 5C, the elongated portion 304 can extend from the fold 303, through the opening in the braided sack 302, and into the catheter 600.
FIG. 5D illustrates the elongated portion 304 exiting the catheter 600, entering the braided sack portion 302 through the free open end 314, and winding within the sack 302. As the elongated portion 304 exits the catheter 600, the elongated portion 304 can maintain its circumference 306 as it exits the catheter 600. The elongated portion 304 can wind or loop within the aneurysm sac 12 in response to contacting an interior surface of the expanded braided sack 302. Additionally, or alternatively, the elongated portion 304 can include memory shape material having a predetermined shape and a deformed shape. The predetermined shape can be a complex looped shape, and the deformed shape can be substantially straight. The elongated portion 304 can wind or loop within the aneurysm sac 12 in response to the memory shape material moving from the deformed shape toward the predetermined shape as the elongated portion 304 contacts blood as it exits the catheter 600. Additionally, or alternatively, the elongated portion 304 can include a flexible elastically deformable material having a relaxed shape that is a looped shape. The flexible elastically deformable material can be uncoiled to a substantially straight strand during delivery through a catheter and can collapse into the looped shape upon exiting the catheter 12.
At the instant illustrated in FIG. 5D the detachment feature 330 can remain attached to a delivery system. While the implant 300 is attached to the delivery system, the delivery system can be pulled proximally to withdraw all or portions of the implant 300. The delivery system can subsequently be pushed distally to reposition the implant 300.
FIG. 5E illustrates the implant 300 in a final implanted configuration such as described in relation to FIG. 4B. The detachment feature 330 can be moved distally by the delivery system past the plane of the aneurysm 16, through the open end 314 of the expanded sack portion 302, and into the aneurysm sac 12 prior to detachment from the delivery system. The elongated portion 304 can have a predetermined shape configured to facilitate the movement of the detachment feature 314 past the plane of the aneurysm neck 16 once the implant 300 is implanted. Additionally, or alternatively, the delivery system can be manipulated to place the detachment feature 314 within the sack portion 302. Once the implant 300 is implanted as illustrated in FIG. 5E, the delivery system can be detached and withdrawn, and the microcatheter 600 can be moved or extracted from the patient.
The open end 314 can remain open at the completion of the implantation, and the elongated portion 304, once secured within the sack 302, can be coiled near the opening defined by the open end 314 in such a way that blood flow is obstructed from entering the opening. In other words, sack 302 can occlude a portion of the neck 16 around the perimeter of the neck, and the elongated portion 304 can occlude the neck 16 at the opening in the sack 302 defined by the open end 314.
FIG. 6A illustrates an example implant 300 a in a collapsed or delivery configuration. In the delivery configuration, the implant 300 a can be collapsed to a size that can be delivered to a treatment site through a catheter inserted in vasculature of a patient. FIG. 6B illustrates the example implant 300 a illustrated in FIG. 6A in an expanded or implanted configuration. In the implanted configuration, the implant 300 a can be positioned in a sac 12 of an aneurysm 10 to divert blood flow from a neck 16 of the aneurysm 10 and fill the sac 12 with embolic material. The embolic material in the aneurysm sac 12 can promote the formation of a thrombotic mass in the aneurysm 10, and the diversion of blood flow from the aneurysm neck 16 can induce venous stasis in the aneurysm and reduce the likelihood that the aneurysm recanalizes after an aneurysm treatment procedure.
Comparing the example implant 300 a illustrated in FIGS. 6A and 6B to the implant 300 illustrated in FIGS. 4A through 5E, the elongated portion 304 a of the implant 300 a in FIGS. 6A and 6B can be an embolic coil 304 a rather than a braid 304 as illustrated in FIGS. 4A through 5E. The implant 300 a illustrated in FIGS. 6A and 6B can be implanted following a procedure like that illustrated in FIGS. 5A through 5E.
Referring collectively to FIGS. 6A and 6B, the implant 300 a can include the embolic coil 304 a, an expandable braided sack portion 302 a, a detachment feature 330 a, and a connecting band 322 joining the embolic coil 304 a to the expandable braid 302 a. The expandable braided sack portion 302 a can be braided. Portions of the implant 300 a, including the embolic coil 304 a, can be made from a memory shape material having a predetermined shape and a deformed shape. The memory shape material can be in the deformed shape when the implant 300 a is in the delivery configuration and can move toward the predetermined shape when the implant 300 a is in the expanded or implanted configuration. When expanded or implanted, the memory shape material can be restricted by anatomical geometries and the memory shape material can take a shape that approaches the predetermined shape but does not match the predetermined shape due to the anatomical restrictions.
The detachment feature 330 a can be joined to the elongated portion 304 a, and the detachment feature 330 a can be detachably attached to a delivery system when the implant 300 a is delivered through a catheter to a treatment site.
Referring to FIG. 6A, in the delivery configuration, the detachment feature 330 a can be positioned at the proximal end 312 a of the implant 300 a, the elongated portion 304 can extend distally from the detachment feature 330 a to the connecting band 322, the braided portion 302 a can extend distally from the connecting band 322, and the braided portion 302 a can have a free open end 314 a positioned at a distal end of the implant 300 a. Strands of the braided portion 302 a at the open end 314 a can be free, cut ends; or, alternatively, the strands at the open end 314 a be closed, meaning strands within the braid at the free open end 314 a are attached to each other by glue, weld, etc. or the strands bend back at the open end 314 a. Free cut ends can have an advantage of being easier to manufacture while the closed strand ends can have an advantage of being more atraumatic compared to the cut ends.
Referring to FIGS. 6A and 6B, the implant 300 a can include memory shape material and can be pre-shaped such that the expandable braided sack portion 302 a forms a globular or spherical shape and the braid can have a fold 303 a near the connecting band 322. The memory shape material can be heat set into the predetermined shape. The implanted shape illustrated in FIG. 6B can be based on the predetermined shape and the shape of the interior wall 14 of the aneurysm 10. To collapse the implant from the predetermined shape so that it can be delivered through a catheter, the embolic coil 304 a can be extended and straightened, the sack portion 302 a can be inverted and stretched, and the fold 303 can be opened and flattened.
Referring to FIG. 6B, in the implanted configuration, the expandable braided sack portion 302 a can expand to contact a majority of the interior wall 14 of the aneurysm 10. The fold 303 a can be positioned near a distal surface 15 of the aneurysm wall 14. The embolic coil 304 a can wind within the aneurysm sac 12 and within the braided sack portion 302 a. By anchoring within the sac 12, the expandable braided sack portion 302 a can maintain proper positioning of the implant 300 a in the aneurysm 10 and prevent portions of the implant 300 a, such as the embolic coil 304 a, from extending into a blood vessel 20 a, 20 b, 21 or exiting the aneurysm sac 12.
The free end 314 a of the expandable braided sack portion 302 a can define an opening in the sack when the implant 300 a is in the implanted or pre-shaped configuration, and when implanted, the opening can be positioned near the aneurysm neck 16. The opening can be sized such that a portion of the expandable braided sack portion 302 a extends across the aneurysm neck 16 to occlude the neck. The embolic coil 304 a can enter the aneurysm sac 12 and the sack of the expandable braided sack portion 302 a through the opening. The elongated portion 304 a can wind or loop around in a complex coiled shape within the expandable braided sack portion 302 a and within the aneurysm sac 12. The looped elongated portion 304 a can press against the braided sack 302 a and provide a force against an interior surface of the braided sack 302 a to press an exterior surface of the braided sack 302 a to the aneurysm wall 14 to further secure the anchoring of the braided sack 302 a within the aneurysm sac 12.
The looped embolic coil 304 a can fill a majority of the aneurysm sac 12. The implanted braided sack 302 a can be a braided mesh with a porosity sized to inhibit blood flow into the aneurysm 10.
FIG. 7 is a flow diagram outlining example method steps for treating an aneurysm. The method steps can be implemented by example devices presented herein or by other means as would be known to one of ordinary skill in the art.
Referring to method 700 outlined in FIG. 7, in step 702, an implant having an expandable portion and an embolic coiling portion can be provided. In step 704, the embolic coiling portion can be detachably attached to a delivery system. In step 706, the implant can be positioned in a microcatheter with the embolic coiling portion extending distally from a proximal end of the implant, the expandable portion extending proximally form the distal end of the implant, and the expandable portion being unattached to the delivery system. In step 708, the distal end of the microcatheter can be positioned near an aneurysm neck. In step 710, the implant can be delivered through the microcatheter to the distal end of the microcatheter. In step 712, the expandable portion can be expelled from the distal end of the microcatheter. In step 714, the expandable portion can expand to contact most of the interior wall of the aneurysm. In step 716, the embolic coiling portion can be expelled from the distal end of the microcatheter. In step 718, the embolic coiling portion can be placed to wind within the expanded expandable portion. In step 720, the embolic coiling portion can be detached from the delivery system.
Referring to method 800 outlined in FIG. 8, in step 810, an implant having an embolic portion and a braided portion having a memory shape material can be provided. In step 820, the braided portion can be shaped to have a spherical predetermined shape. In step 830, the embolic portion can be attached to an implant delivery system so that it can later be detached. In step 840, the implant and the delivery system can be positioned within a microcatheter. In step 850, the implant and delivery system can traverse through the microcatheter while the braided portion is unattached to the delivery system. In step 860, the implant can be expelled from the microcatheter.
Step 840 in method 800, positioning the implant and the delivery system in the microcatheter, can include sub steps as illustrated in FIG. 9. In sub step 842, the braided portion can be collapsed to fit within the microcatheter. In sub step 844, the braided portion can be positioned to extend proximally from a distal end of the implant. In sub step 846, the embolic portion can be positioned to extend distally from a proximal end of the implant. In sub step 848, the delivery system can be positioned to extend proximally form the embolic portion.
Step 860 in method 800, expelling the implant from the microcatheter, can include sub steps as illustrated in FIG. 10. In sub step 862, the braided portion can be expelled from the microcatheter. In sub step 864, the braided portion can be expanded to form a sack shape based on the spherical predetermined shape. In sub step 866, the embolic portion can be expelled from the microcatheter. In sub step 868, the embolic portion can be coiled within the sack shape of the braided portion.
The descriptions contained herein are examples of embodiments of the invention and are not intended to limit the scope of the invention. As described herein, the invention contemplates many variations and modifications of an implant, system, or method that can be used to occlude and fill an aneurysm. Variations can include but are not limited to combining elements of various embodiments, utilizing alternative geometries of elements and components described herein, utilizing alternative materials for each component or element (e.g. radiopaque materials, memory shape materials, etc.), utilizing additional components including components to deliver the implant to a treatment site, position the implant at a treatment site, retract the implant, and/or eject a portion of the implant from a catheter, utilizing additional component to perform functions describe herein, and utilizing additional components to perform functions not described herein, for example. These modifications would be apparent to those having ordinary skill in the art to which this invention relates and are intended to be within the scope of the claims which follow.

Claims

1. An implant comprising:

an expandable braided sack portion comprising a free open end;

an elongated looping portion joined to the expandable braided sack portion; and

a detachment feature joined to the elongated looping portion and detachably attached to a delivery system,

wherein the implant is movable from a delivery configuration sized to traverse through a lumen of a catheter of the delivery system to an implanted configuration sized to secure within an aneurysm,

wherein in the delivery configuration, the expandable braided sack portion extends from a distal end of the implant, the elongated looping portion extends proximally from the expandable braided sack portion, and the detachment feature is positioned approximate a proximal end of the implant,

wherein in the delivery configuration, the expandable braided sack portion is unattached to the delivery system,

wherein in the implanted configuration, the expandable braided sack portion is sized to contact a majority of an interior wall of the aneurysm, is sized to contain the elongated looping portion, and is sized to occlude at least a portion of a neck of the aneurysm,

wherein in the implanted configuration, the free open end is positioned to be placed approximate the neck, and

wherein in the implanted configuration, the elongated looping portion is sized to wind within the expandable braided sack portion.

2. The implant of claim 1, wherein, in the delivery configuration, the implant comprises a fold approximate the distal end of the implant, the expandable braided sack portion encompasses at least a portion of the elongated looping portion, and the free open end encircles the elongated looping portion.

3. The implant of claim 1, wherein, in the delivery configuration, the free open end is positioned at the distal end of the implant.

4. The implant of claim 1, wherein, in the implanted configuration, a fold defining a boundary between the elongated looping portion and the expandable braided sack portion is positioned to be implanted approximate a distal surface of the interior aneurysm wall.

5. The implant of claim 1, wherein the elongated looping portion and the expandable braided sack portion are portions of a contiguous tubular braid.

6. The implant of claim 5, wherein, in the implanted configuration, the elongated looping portion comprises a substantially uniform circumference along a majority of its length, the length measurable from the detachment feature to a fold defining a boundary between the elongated looping portion and the expandable braided sack portion.

7. The implant of claim 1, wherein the elongated looping portion comprises an embolic coil, and wherein the expandable braided sack portion comprises a tubular braid.

8. The implant of claim 1, wherein the implant consists of the expandable braided sack portion, the elongated looping portion, and the detachment feature.

9. The implant of claim 1, wherein the detachment feature remains attached to the delivery system after detachment from the implant.

10. An implant comprising:

an expandable braided sack portion comprising a free open end;

an embolic coil joined to the expandable braided sack portion by a connecting band; and

a detachment feature joined to the embolic coil and detachably attached to a delivery system,

wherein in the delivery configuration, the expandable braided sack portion extends from a distal end of the implant, the embolic coil extends proximally from the expandable braided sack portion, and the detachment feature is positioned approximate a proximal end of the implant,

wherein in the implanted configuration, the expandable braided sack portion is sized to contact a majority of an interior wall of the aneurysm, is sized to contain the embolic coil, and is sized to occlude at least a portion of a neck of the aneurysm,

wherein in the implanted configuration, the embolic coil is sized to fit within the expandable braided sack portion.

11. The implant of claim 10, wherein, in the delivery configuration, the implant comprises a fold approximate the distal end of the implant and a fold approximate the connecting band, the expandable braided sack portion encompasses at least a portion of the embolic coil, and the free open end encircles the embolic coil.

12. The implant of claim 10, wherein, in the delivery configuration, the free open end is positioned at the distal end of the implant.

13. The implant of claim 10, wherein, in the implanted configuration, the fold approximate the distal end of the implant is positioned to be implanted approximate a distal surface of the interior aneurysm wall.

14. The implant of claim 10, wherein the implant consists of the expandable braided sack portion, the embolic coil, the connecting band, and the detachment feature.

15. The implant of claim 10, wherein the detachment feature remains attached to the delivery system after detachment from the implant.

16. An implant comprising:

an expandable braided sack portion comprising a free open end;

an elongated looping portion joined to the expandable braided sack portion; and

wherein in the implanted configuration, the free open end is positioned to be placed approximate the neck,

wherein in the implanted configuration, the elongated looping portion is sized to wind within the expandable braided sack portion, and

wherein in the implanted configuration, the expandable braided portion is inverted.

17. The implant of claim 16, wherein, in the delivery configuration, the implant comprises a fold separating the expandable braided sack portion and the elongated looping portion.

18. The implant of claim 17, wherein in the implanted configuration, the fold is positioned near a distal surface of the aneurysm wall.

19. The implant of claim 16, wherein the elongated looping portion and the expandable braided sack portion are portions of a contiguous tubular braid.

20. The implant of claim 16, wherein the elongated looping portion comprises an embolic coil, and wherein the expandable braided sack portion comprises a tubular braid.